|
The French-American Chamber of Commerce of San
Francisco
cordially invites you to join them to a:
Life
Science Breakfast
“From Market to Discovery and Back, the Value of Early Commercialization.”
Tuesday
September 25th.
7:30 am - 9:30 am @
Swissnex
730 Montgomery Street
San Francisco
Registration
Breakfast will be served
Swissnex connects the dots in science, education,
art and innovation,
between Switzerland and Western North America
Sponsored by Invest in
Northern France.
 Due to increased competition
and difficulty in bringing new and innovative products to market,
aligning R&D and commercial functions has been an area of increasing
focus for the last 15 years. The industry has been forced to define
ways to address these challenges and ensure that scarce R&D and
commercial resources are focused on the most commercially viable
targets. Attempts to address these challenges have resulted in various
models incorporating cross-functional project teams, aligning around a
therapeutic area, or establishing cross-functional portfolio
decision-making bodies.
This session will
cover the drivers for early commercialization models improvements,
explore the paradoxes it can create and what it takes to develop the
right product for tomorrow leveraging relationships between sciences,
sales and marketing.
SPEAKERS
|
|
 Jean-Marc Niemetz,
Vice President of Global Life Science at Capgemini
Jean-Marc Neimetz is a Vice President and the Life Sciences
Industry Leader for Capgemini North America. He joined the New
York office in 1999.
Over his 17+ years of consulting experience, Jean-Marc has been
advising leading life sciences companies on corporate strategy and
organization, product life cycle management, marketing and sales
effectiveness, research and development.
As a practice leader, he is also overseeing the activities of the
Life sciences teams in North America.
Jean Marc is a graduate from the Paris Business School and Member
of the President's Council of the New York Academy of Science.
He is personally involved in the publication of Vision and
Reality, Capgemini annual global industry survey.
Capgemini Life Science's practice has a proven track record
working with leading life sciences organizations. The firm has
more than 500 dedicated professionals and 2,500 affiliated
consultants in 19 countries, with specific expertise in the field
of Life Sciences.
Piyush
Jain,
Director, Commercial Pipeline Strategy
Piyush Jain
is currently the Director of Commercial Pipeline Strategy for
Tissue Growth and Repair Business Unit at Genentech.
He
has had a successful pharmaceutical industry career, with over 10
yrs of strategic planning, sales and marketing experience in the
industry. He has held numerous leadership roles in commercial
product management, strategic planning, portfolio and lifecycle
planning, partnership interactions, cross commercial and
organizational leadership and team building. His career has
spanned a number of companies including Genentech and
Pfizer. He has an MBA from
University of
Michigan at
Ann Arbor, and a BS in Electrical
Engineering from Indian Institute of Technology,
New Delhi.
|
| |
Sally Meadows
Sally is currently Senior Director,
Inflammation Disease Area Management, at Roche Pharmaceuticals.
Previously she was Director of Business Analysis at Scios Inc. and
Business Unit Manager at Roche Laboratories. Her experience
includes global marketing, business development, sales
operations and management, market research, and strategic planning
in both biotechnology and large pharmaceutical companies. Her
responsibilities have encompassed products in all phases of the
product life cycle including research, early through late clinical
development, launch and on market in a variety of therapeutic
areas including respiratory, rheumatology, autoimmune,
cardiovascular, genitourinary, and pain.
She received an MBA from
San Jose
State
University
and a BS in Chemistry from the
University
of
Maryland College Park.
MODERATOR
 Fred Dorey:
special counsel
in the Life Sciences practice group of the
Cooley Godward Business department.
Mr.
Dorey represents a range of biotechnology, instrumentation and other technology
companies at various stages of development from start-up and incorporation
through licensing, corporate partnering and major collaboration transactions.
He also has extensive experience negotiating clinical trial, sponsored research
and intellectual property agreements. In addition, Mr. Dorey advises a number of
major foundations, research institutions, and individuals regarding their
participation in biomedical research endeavors, including investment, licensing
and commercialization activities.
Before joining the Firm, Mr. Dorey was the first president of the Bay Area
Bioscience Center, a consortium of research universities, biotechnology
companies and local governments organized to support bioscience development
in Northern California. He also served as part-time in house counsel
for several biotech companies including Tularik, Geron and Shaman.
Previously, he had served as general counsel and corporate secretary for
British Petroleum in San Francisco, where he was chief legal advisor for the
Fortune 500-sized subsidiary that handled all BP oil exploration and
production in the United States.
He has also served as a regulatory enforcement lawyer and assistant office
director for the Department of Energy in Washington DC. Mr. Dorey received a
JD from the University of Southern California Law Center, where he was
president of the Student Bar Association. Before law school he served
as a White House Intern in the office of the Director of the Peace Corps in
Washington DC. He received a BS in Engineering from University of
California, Los Angeles. Mr. Dorey currently serves as a director of the
American Liver Foundation, the World Affairs Council of Northern California,
the Bay Area Bioscience Center, the San Francisco Boys Chorus and the
National Kidney Foundation of Northern California. He is also a
director of a privately held research instrumentation company.
He is a member of the State Bar of California and the District of Columbia Bar.
|
REGISTRATION
$30 at the door
Or please mail or fax the reservation Card below
Reservation Card - Life Science
Breakfast
Please reserve ___ seat (s) at $20 per person (for Members).
Please reserve ___ seat (s) at $25 per person (for Non Members).
Name________________________________________________________________
Company______________________________________________________________
Address_______________________________________________________________
Email address______________________________________________ for
confirmation
Phone number
__________________________________________________________
Visa/MC
Number________________________________________________________
Expires________Signature_________________________________________________
Please make checks payable to
FACCSF
Please, fax this coupon to the FACCSF
Registration price valid until 5-days
Prior to the
event
date
Cancellations must be made 5-days prior to the event date
Any cancellation within a 5-day period of the scheduled date will
not be refunded
French-American Chamber of Commerce
703 Market Street, Suite 450, San Francisco, CA 94103
Tel: 415 442 4717 / Fax 415 442 4621|
|
